Pharma Journalist 8791 posts 0 comments

Fortress Biotech announced that Caelum Biosciences has signed a strategic agreement with Alexion Pharmaceuticals to advance the development of CAEL-101 for light chain (AL) amyloidosis.…
Read More...

Cryoport, Inc. will celebrate the official opening of its most recent Global Logistics Center, based in Amsterdam, The Netherlands. The ribbon-cutting ceremony will be attended by…
Read More...

The Lubrizol Corporation announces its contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, is partnering with leading Indian…
Read More...

Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical…
Read More...

Pfizer Inc. and Eli Lilly and Company announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis…
Read More...

Eureka Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for ET140202 ARTEMIS T-cell therapy in…
Read More...

Cannassure Therapeutics announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation. Cannika will operate out of the Cannassure campus,…
Read More...

Genentech announced the decision to discontinue CREAD 1 and CREAD 2 (BN29552 and BN29553) Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with…
Read More...

SGS announced that it has invested GBP 7.6 million in its facility in Glasgow, UK to expand the capabilities and capacity for testing cell banks and routine bulk harvest for vaccines,…
Read More...

Fresenius Kabi announced the immediate availability in the United States of Leucovorin Calcium Injection, USP, a medication indicated to counteract the toxicity and diminish the effects…
Read More...